Martins Tássia Joi, Negri Laisa Bonafim, Pernomian Laena, Faial Kelson do Carmo Freitas, Xue Congcong, Akhimie Regina N, Hamblin Michael R, Turro Claudia, da Silva Roberto S
Department of Chemistry, Faculty of Philosophy, Sciences and Letters of Ribeirão Preto University of São Paulo, Ribeirão Preto, Brazil.
Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, United States.
Front Mol Biosci. 2021 Jan 12;7:595830. doi: 10.3389/fmolb.2020.595830. eCollection 2020.
This work presents a new procedure to synthesize ruthenium-phthalocyanine complexes and uses diverse spectroscopic techniques to characterize [RuCl(Pc)DMSO] (Pc = phthalocyanine) and -[Ru(Pc)(4-ampy)] (4-ampy = 4-aminopyridine). The triplet excited-state lifetimes of measured by nanosecond transient absorption showed that two processes occurred, one around 15 ns and the other around 3.8 μs. Axial ligands seemed to affect the singlet oxygen quantum yield. Yields of 0.62 and 0.14 were achieved for and , respectively. The lower value obtained for probably resulted from secondary reactions of singlet oxygen in the presence of the ruthenium complex. We also investigate how axial ligands in the ruthenium-phthalocyanine complexes affect their photo-bioactivity in B16F10 murine melanoma cells. In the case of at 1 μmol/L, photosensitization with 5.95 J/cm provided B16F10 cell viability of 6%, showing that was more active than at the same concentration. Furthermore, was detected intracellularly in B16F10 cell extracts. The behavior of the evaluated ruthenium-phthalocyanine complexes point to the potential use of as a metal-based drug in clinical therapy. Changes in axial ligands can modulate the photosensitizer activity of the ruthenium phthalocyanine complexes.
这项工作提出了一种合成钌 - 酞菁配合物的新方法,并使用多种光谱技术对[RuCl(Pc)DMSO](Pc = 酞菁)和 -[Ru(Pc)(4 - ampy)](4 - ampy = 4 - 氨基吡啶)进行表征。通过纳秒瞬态吸收测量的三重激发态寿命表明发生了两个过程,一个在15 ns左右,另一个在3.8 μs左右。轴向配体似乎影响单线态氧量子产率。[RuCl(Pc)DMSO]和 -[Ru(Pc)(4 - ampy)]的产率分别为0.62和0.14。[Ru(Pc)(4 - ampy)]获得的较低值可能是由于在钌配合物存在下单线态氧的二级反应所致。我们还研究了钌 - 酞菁配合物中的轴向配体如何影响它们在B16F10小鼠黑色素瘤细胞中的光生物活性。在1 μmol/L的[RuCl(Pc)DMSO]情况下,用5.95 J/cm²的光进行光敏化处理后,B16F10细胞活力为6%,表明在相同浓度下[RuCl(Pc)DMSO]比 -[Ru(Pc)(4 - ampy)]更具活性。此外,在B16F10细胞提取物中检测到了[RuCl(Pc)DMSO]。所评估的钌 - 酞菁配合物的行为表明[RuCl(Pc)DMSO]有作为金属基药物用于临床治疗的潜力。轴向配体的变化可以调节钌酞菁配合物的光敏剂活性。